| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1432-2277.1998.TB01121.X |
| P698 | PubMed publication ID | 9664985 |
| P2093 | author name string | Nowak G | |
| Ericzon BG | |||
| Einarsson C | |||
| Wang FH | |||
| Duraj F | |||
| Söderdahl G | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration | Q28334026 | ||
| Cyclosporin A pharmacokinetics in liver transplant recipients in relation to biliary T-tube clamping and liver dysfunction | Q34392206 | ||
| Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis | Q39514969 | ||
| The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells | Q41544971 | ||
| Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. | Q42199158 | ||
| The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis | Q49110706 | ||
| Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. | Q50878460 | ||
| Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. | Q54072767 | ||
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | S231-8 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Transplant International | Q15762140 |
| P1476 | title | Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation | |
| P478 | volume | 11 Suppl 1 |
| Q73544640 | A prospective randomized study comparing poly-ATG to mono-OKT3 clonal antibodies for the first rejection therapy after kidney transplantation: long-term results |
| Q77068653 | ALG versus OKT3 for treatment of steroid-resistant rejection in renal transplantation: ten-year follow-up results of a randomized trial |
| Q38995172 | Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects. |
| Q37691180 | Antibody immunosuppressive therapy in solid-organ transplant: Part I. |
| Q24236673 | Bile acids for liver-transplanted patients |
| Q24246504 | Bile acids for liver-transplanted patients |
| Q34631304 | Cholelithiasis in pediatric organ transplantation: detection and management |
| Q38259459 | Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials. |
| Q33357529 | Intraoperative anti-thymocyte globulin-fresenius bolus induction therapy in kidney transplantation |
| Q73012986 | Low-dose ATG is effective in treatment of acute rejection episodes |
| Q26823090 | New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity |
| Q44373304 | Treatment options for biliary complications after orthotopic liver transplantation |
Search more.